Three additional APIs have been prequalified by the WHO, expanding access to essential medicines in developing countries.
July 2026SNF announces a $20M investment in sustainable synthesis technologies to reduce environmental impact by 50% by 2030.
June 2026Strategic partnership established to distribute SNF products across 15 African nations, improving access to affordable medicines.
May 2026Select your preferred language to translate this website.
Insert Translator Plugin Here